How to get sermorelin has a longer answer than most compounds this site covers, because one of the routes is a real prescription rather than a theoretical one. That changes the shape of the decision. Below, the routes are sorted by what each asks of you in time, money and paperwork, and the page ends where readers realistically land rather than where a buying guide would prefer they landed.
Key takeaways
- The prescription route exists for this compound and does not for most of the peptides sold beside it. Sermorelin acetate was a component of an FDA-approved drug product, which is one of the conditions section 503A sets.
- Sermorelin is absent from FDA's Category 2 bulk substances list in every section. Ibutamoren mesylate is listed under both 503A and 503B, and ipamorelin acetate, GHRP-2 and GHRP-6 are listed as well.
- The highest-friction route buys the most recourse. A prescriber and a licensed dispenser are attached to a pharmacy fill and to nothing else on the list.
- The research-supplier route is the lowest friction and the one most readers take: a sealed 10 mg powder under laboratory-use terms, $36.00 with the code, with a lot certificate to read first.
- No route changes the evidence. The approved indications were paediatric growth hormone deficiency and pituitary diagnostics, and PubMed returns zero papers for sermorelin and anti-aging.
The vendor we point lifters to
Sermorelin from Ascension Peptides
Independently assayed material, dispatched from the US. The vial drops by half with the code below.
The published certificate for lot 38-01260229 assays this vial at 11.31 mg against a 10 mg label, and reports purity and quantity only, with no endotoxin or sterility testing. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.
- Lot certificate published, purity and quantity
- Free delivery above $250
- Same-day dispatch on orders before 2pm CST
Research material, laboratory use only, not for human consumption. Affiliate links: we may earn a commission at no extra cost to you. Pricing verified September 6, 2026.
How to get sermorelin: four routes, sorted by friction
| Route | What it asks of you | Elapsed time | What you end up holding |
|---|---|---|---|
| Compounding pharmacy on prescription | A prescriber, a clinical reason, bloodwork, a pharmacy that fills it | Weeks, mostly waiting on labs and appointments | A dispensed preparation with a prescription behind it |
| Telehealth hormone clinic | An intake form, labs, usually a recurring plan | Days to a couple of weeks | The same pharmacy route with the admin pre-solved |
| Research supplier | Reading a certificate and accepting laboratory-use terms | Two to five days domestically | A sealed lyophilised vial and a lot report |
| Overseas marketplace | Tolerance for losing the money | Weeks, sometimes never | A parcel, a customs risk, no recourse |
The ordering is deliberate. Friction and recourse move together, and every row that removes a requirement also removes somebody who is accountable when the transaction fails.
Route one: the prescription that genuinely exists
Most pages about peptides in this category tell readers there is no legitimate route. For sermorelin that is simply false, and the reason is specific.
Sermorelin was an approved drug. EMD Serono held it as Geref under two applications: NDA 019863, the diagnostic presentation at 0.05 mg per ampoule, with submissions from May 1991, and NDA 020443, the therapeutic presentation at 0.5 mg and 1 mg per vial, originally approved on September 26, 1997. Both are listed as discontinued in Drugs@FDA. The product record carries the Federal Register determination that the product was not discontinued or withdrawn for safety or effectiveness reasons, so this was a commercial exit rather than a safety action. DailyMed returns no current label, because nothing is marketed.
Under section 503A a compounder may work with a bulk drug substance that is a component of an FDA-approved drug product, even where no USP monograph exists. Sermorelin acetate was exactly that. The route never required a nomination to any list, and sermorelin is correspondingly absent from FDA's Category 2 bulk substances catalogue in every section, active and withdrawn.
The comparison makes the point concrete. Ibutamoren mesylate carries a Category 2 listing under both 503A and 503B. Ipamorelin acetate is listed under 503B, and so are GHRP-2 and GHRP-6. Kisspeptin-10 is listed under 503A. Sermorelin appears in none of them. A reader who has learned that growth hormone secretagogues are all in the same regulatory bucket has learned something true about the others and wrong about this one.
What the route costs is time. A prescriber has to be willing, there is bloodwork, and a pharmacy has to choose to fill it. The detail of what a prescriber asks for is on our sermorelin prescription page.
Route two: telehealth, which sells the friction back to you
Telehealth hormone and longevity clinics package route one as a product. The intake, the lab requisition, the prescriber and the pharmacy relationship arrive together, usually on a recurring plan.
The trade is straightforward. You are paying for somebody else to have solved the two hard parts, which are finding a prescriber and finding a pharmacy. What you frequently give up is price transparency and the ability to leave without notice, since multi-month minimums and subscription structures are common in this segment.
We do not publish a monthly figure for this route because we do not have one we can verify, and inventing one to fill a column would make this page look more useful while making it less true.
Route three: the research supplier, where most readers land
This is the route the majority of people searching this query actually take, so it deserves description rather than either a warning or a sales pitch.
A research supplier sells a sealed vial of lyophilised powder under laboratory-use terms. There is no prescriber, no dosing guidance and no human-use claim, because a seller attaching those to a product with no current label has changed what it is selling in regulatory terms. What a good supplier does provide is documentation, and that is the only axis on which these sellers can be compared honestly.
The worked example here is a 10 mg presentation and lot 38-01260229, analysed by MZ Biolabs of Tucson, Arizona on February 7, 2026 by HPLC-UV-MS: 99.79% purity across four detected peaks, and 11.31 mg measured against a 10 mg label. We checked the identity claim independently; the certificate's sequence resolves to YADAIFTNSYRKVLGQLSARKLLQDIMSR, twenty-nine residues with a C-terminal amide, and PubChem CID 16132413 returns the matching formula and mass, C149H246N44O42S at 3357.9 g/mol.
The honest limitation belongs in the same paragraph. That certificate reports purity and quantity only. It carries no endotoxin test and no sterility test, and FDA's stated concern for this whole peptide class is the "risk for immunogenicity" arising from "the potential for aggregation and peptide-related impurities". Scope is a property of the lot rather than of the vendor, and the full read of the document sits on our listing checklist.
On price, the ladder is $99.99 list, $72.00 site, and $36.00 with the code, which is $3.60 per milligram on the label and $3.18 on the 11.31 mg that lot assayed.
Route four: the one whose only advantage is the sticker
An overseas marketplace order adds customs exposure, adds transit days, and adds heat. Lyophilised powder survives shipping better than a solution, but every extra day is another day at ambient temperature and a border adds days nobody is counting.
The real cost is recourse. A domestic order that goes wrong involves a business entity, written terms and a reversible payment rail. An international order that goes wrong involves a tracking number that stopped updating in a different jurisdiction. The saving rarely covers that, and the comparison is worked through on our US supply page.
Where the decision actually sits
The route question is easier to answer than the question underneath it, so here is the part a lifter should weigh before any of the above.
Sermorelin is a secretagogue. It binds the GHRH receptor on the anterior pituitary and prompts release of the body's own growth hormone. It is not HGH, and buying it is not a way of buying growth hormone at a discount.
The approved evidence was paediatric growth hormone deficiency and pituitary diagnostics. PubMed returns 332 papers mentioning sermorelin, three with it in the title, and zero for sermorelin and anti-aging. ClinicalTrials.gov registers no studies naming the compound, so any trial identifier quoted for it has been invented. The relevant title papers are a 1999 BioDrugs review of children with idiopathic growth hormone deficiency (PMID 18031173) and a 2006 discussion of adult-onset growth hormone insufficiency (PMID 18046908).
That is an unusual position: a compound with a genuine approval history, a genuine prescription route, and no literature covering the reason most people are searching for it. Both halves are true, and a page that gives you only one of them is selling something.
Frequently asked questions
Can I get sermorelin on a prescription in the United States?
The mechanism exists. Sermorelin acetate was a component of an FDA-approved drug product, which is one of the conditions section 503A sets for compounding with a bulk substance that has no USP monograph. Whether a given prescriber will write for it and a given pharmacy will fill it are separate practical questions.
Why is sermorelin easier to obtain legitimately than ipamorelin or MK-677?
Because of its regulatory record rather than any claim about effect. Ibutamoren mesylate carries a Category 2 listing under both 503A and 503B, ipamorelin acetate is listed under 503B, and sermorelin is absent from that list in every section.
Which route is fastest?
A domestic research supplier, which typically means a few days from order to doorstep. It is also the route with no prescriber attached, so the speed is the trade rather than a bonus.
Was sermorelin taken off the market for safety reasons?
No. The FDA product record carries the Federal Register determination that it was not discontinued or withdrawn for safety or effectiveness reasons. Both Geref applications are simply discontinued, and there is no current US label.
Does a prescription route mean the physique claims are supported?
No. The approval was for paediatric growth hormone deficiency and pituitary diagnostics. PubMed returns zero papers for sermorelin and anti-aging, and no registered trial names the compound. The route being legitimate and the marketed use being unstudied are both true at the same time.
This article is for educational purposes only and is not medical advice. Sermorelin was approved as Geref and is now discontinued, with no current US label; material sold by research suppliers is labeled for laboratory use only and not for human consumption. Speak with a qualified healthcare professional before making any decision involving peptides, injections, or off-label compounds.